Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin in Mixed Hypercholesterolemic Patient: Multi Center, Randomized, Double-blind, Parallel-group, Therapeutic Confirmatory Study.

NCT01956201 Phase 3 UNKNOWN

The purpose of this study is to evaluate the efficacy and safety of Atorvastatin and Fenofibrate compared with atorvastatin monotherapy in mixed hypercholesterolemic patients.

Details

Lead sponsor	Chong Kun Dang Pharmaceutical
Phase	Phase 3
Status	UNKNOWN
Enrolment	476
Start date	2013-12
Completion	2016-08

Conditions

• Mixed Hyperlipidemia

Interventions

• Atorvastatin 20mg
• Fenofibrate 160mg
• Placebo (Fenofibrate 160 mg)

Primary outcomes

• The mean percent change of Non-HDL Cholesterol — from baseline at week 8

Countries

South Korea